杜瓦卢马布
放化疗
阶段(地层学)
医学
肺癌
肿瘤科
癌症
内科学
生物
免疫疗法
古生物学
无容量
作者
Ying Cheng,David R. Spigel,Byoung Chul Cho,К. К. Лактионов,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabé,E.L. Buchmeier,John Wen-Cheng Chang,Yoshimasa Shiraishi,Sema Sezgin Göksu,A. Badzio,Anhui Shi,Davey B. Daniel,Nguyễn Thị Thái Hòa,Milada Zemanová
标识
DOI:10.1056/nejmoa2404873
摘要
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent platinum-based chemoradiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI